Gainers
- Ensysce Biosciences (NASDAQ:ENSC) stock increased by 21.4% to $0.5 during Wednesday's pre-market session. The company's market cap stands at $7.5 million.
- AtriCure (NASDAQ:ATRC) stock increased by 18.92% to $35.0. The company's market cap stands at $1.7 billion. As per the press release, Q3 earnings came out yesterday.
- CalciMedica (NASDAQ:CALC) stock increased by 18.32% to $4.65. The market value of their outstanding shares is at $49.9 million.
- Matinas BioPharma Hldgs (AMEX:MTNB) stock moved upwards by 18.27% to $3.3. The company's market cap stands at $16.5 million.
- Cue Biopharma (NASDAQ:CUE) stock rose 15.38% to $1.95. The company's market cap stands at $117.4 million.
- HOOKIPA Pharma (NASDAQ:HOOK) stock rose 14.47% to $4.27. The company's market cap stands at $42.2 million.
Losers
- Applied DNA Sciences (NASDAQ:APDN) shares fell 42.2% to $0.18 during Wednesday's pre-market session. The company's market cap stands at $1.8 million.
- AnaptysBio (NASDAQ:ANAB) shares decreased by 21.43% to $24.2. The market value of their outstanding shares is at $730.8 million.
- Spero Therapeutics (NASDAQ:SPRO) shares fell 19.12% to $1.06. The market value of their outstanding shares is at $57.2 million.
- GlycoMimetics (NASDAQ:GLYC) stock declined by 15.94% to $0.41. The company's market cap stands at $26.5 million.
- Tempest Therapeutics (NASDAQ:TPST) stock declined by 14.13% to $0.94. The company's market cap stands at $23.8 million.
- CVRx (NASDAQ:CVRX) stock fell 11.92% to $9.46. The company's market cap stands at $205.3 million. As per the news, the Q3 earnings report came out yesterday.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
